Stonepine Capital Management, LLC Leap Therapeutics, Inc. Call Options Transaction History
Stonepine Capital Management, LLC
- $110 Billion
- Q2 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding LPTX
# of Institutions
1Shares Held
265KCall Options Held
0Put Options Held
0About LEAP THERAPEUTICS, INC.
- Ticker LPTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 99,021,400
- Market Cap $413M
- Description
- Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate can...